✨ Free AI Report
Sensorion: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Sensorion
Company Research

Sensorion: Business Overview, Financials & Competitive Analysis

Sensorion is a pioneering clinical-stage and gene therapy biotech company which specializes in the development of novel therapies to treat, prevent and restore within the field of hearing loss disorders. This addresse...

Analyst-debate audio for Sensorion

AskCyborg analysts argue the bull and bear cases for Sensorion across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
5/ 10Mixed

Cyborg Score thesis

Emerging gene therapy player with pharma backing targeting rare genetic hearing disorders, positioned in high-value niche market...

Read the full analyst-debate transcript →
Industry Biotechnology / Clinical-Stage Gene Therapy
2 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Sensorion Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Sensorion Overview

Pro stress-test →

Sensorion is a pioneering clinical-stage and gene therapy biotech company which specializes in the development of novel therapies to treat, prevent and restore within the field of hearing loss disorders. This addresses hearing loss disorders, a significant global unmet medical need.

Strategic Profile

Pro stress-test →

The company has built a unique R&D technology platform to expand its understanding of the pathophysiology and etiology of inner ear related diseases, enabling it to select the best targets and mechanisms of action for drug candidates. Recent strategic backing from Sanofi ($20 million) alongside €60 million total financing demonstrates confidence in the pipeline focused on genetic medicine.

Competitive Landscape

Pro stress-test →

Sensorion competes in rare genetic hearing loss therapy space against larger diversified pharma companies (Novartis, Roche) and emerging gene therapy platforms. Strategic collaboration with Institut Pasteur provides differentiation in genetic hearing loss. Limited direct pure-play competitors in this specific niche.

Industry Context

Sensorion operates in Biotechnology / Clinical-Stage Gene Therapy.

Key facts

Founded: 2009 · Headquarters: Montpellier, France · Employees: 63 · Revenue: $6.65M (2024) · Market cap: $178M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Sensorion.

  • Sanofi strategic investment (Jan 2026) signals confidence in gene therapy approach and de-risks capital requirements
  • Dual-pronged strategy: near-term small molecule (SENS-401) in Phase 2 for acquired hearing loss plus gene therapies for monogenic deafness
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • January 2026€60 million financing secured with €20M strategic investment from Sanofi
  • January 2026CEO Nawal Ouzren steps down; Amit Munshi assumes leadership
  • +1 moreTrack every material event for Sensorion as it happens. Explore monitoring →
Get alerted when Sensorion has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Hearing Loss Gene Therapy PlatformLarge pharma exploring gene therapy for hereditary hearing loss→Cochlear ImplantsMedical device partner on SENS-401 Cochlear study→

Compare Sensorion with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Sensorion operates in Biotechnology / Clinical-Stage Gene Therapy. See how the rest of the sector scores on the Cyborg framework.

Top companies in Biotechnology by Cyborg Score

Browse Biotechnology / Clinical-Stage Gene Therapy research →
NEW · MCP server

Ask your AI assistant about Sensorion

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Sensorion and its top competitor on Cyborg Score”
“What did Sensorion do this quarter?”
“Is Sensorion a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Sensorion do?+
Sensorion is a pioneering clinical-stage and gene therapy biotech company which specializes in the development of novel therapies to treat, prevent and restore within the field of hearing loss disorders. This addresse...
What is Sensorion's Cyborg Score?+
Sensorion has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Sensorion's main competitors?+
Named competitors include Hearing Loss Gene Therapy Platform, Cochlear Implants. The full competitive landscape is in the AskCyborg report.
How can I get the full Sensorion research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Sensorion research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Sensorion over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Biotechnology research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Abivax SA8Bavarian Nordic A/S8Beam Therapeutics Inc.8CG Oncology, Inc.8Cogent Biosciences, Inc.8COMPASS Pathways plc8CSL Limited8Eckert & Ziegler SE8Krystal Biotech, Inc.8Legend BiotechTop companies in Biotechnology by Cyborg Score